Inventor · disambiguated record
Stephen Frederick Moss
Also filed as: MOSS STEPHEN F · MOSS STEPHEN FREDERICK
17 granted patents·14 pending applications·234 citations·filing 1983–2023
94Inventor score
Files withGLAXO GROUP LTD9SMITHKLINE BEECHAM PLC5BEECHAM GROUP PLC3NEW PHARMA LICENCE HOLDINGS LTD3GLAXOSMITHKLINE IP DEV LTD2
Top patents by PatentIndex Score
31 records- 0192US7601837B2Quinoline derivatives and their use as 5-HT6 ligandsGLAXO GROUP LTD·Filed 2008·Granted Oct 13, 2009·15 cites·3 claims
- 0292US6316450B1CompoundsSMITHKLINE BEECHAM PLC·Filed 1998·Granted Nov 13, 2001·71 cites·7 claims
- 0390US7799774B2Quinoline derivatives and their use as 5-HT6 ligandsGLAXO GROUP LTD·Filed 2009·Granted Sep 21, 2010·11 cites·15 claims
- 0489US7977337B2Quinoline derivatives and their use as 5-HT6 ligandsGLAXO GROUP LTD·Filed 2010·Granted Jul 12, 2011·11 cites·10 claims
- 0589US7452888B2Quinoline derivatives and their use as 5-ht6 ligandsGLAXO GROUP LTD·Filed 2003·Granted Nov 18, 2008·23 cites·11 claims
- 0688US8236947B2Quinoline derivatives and their use as 5-HT6 ligandsAHMED MAHMOOD·Filed 2011·Granted Aug 7, 2012·11 cites·18 claims
- 0788US4505926AQuaternary amino imidazolidines, compositions and useBEECHAM GROUP PLC·Filed 1983·Granted Mar 19, 1985·27 cites·7 claims
- 0884US6849644B2Isoquinoline derivatives useful in the treatment of CNS disordersSMITHKLINE BEECHAM PLC·Filed 2001·Granted Feb 1, 2005·22 cites·11 claims
- 0977US7439243B2Piperazinyl-quinoline derivatives useful for the treatment of CNS disordersGLAXO GROUP LTD·Filed 2004·Granted Oct 21, 2008·9 cites·12 claims
- 1071US2023322858A1Polymyxin derivatives and their use in combination therapy together with different antibioticsSPERO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1165US10683307B2Compounds for use in antibacterial applicationsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Jun 16, 2020·0 cites·7 claims
- 1264US4602041ABenzylideneamino- and phenylacetylguanidines and their pharmaceutical usesBEECHAM GROUP PLC·Filed 1983·Granted Jul 22, 1986·9 cites·15 claims
- 1363US6548504B1CompoundsSMITHKLINE BEECHAM PLC·Filed 1999·Granted Apr 15, 2003·20 cites·10 claims
- 1463US2023340026A1CompoundsNEW PHARMA LICENCE HOLDINGS LTD·Filed 2023·Application pending·0 cites
- 1559US2021221848A1Polymyxin derivatives and their use in combination therapy together with different antibioticsSPERO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1657US10364254B2Compounds for use in antibacterial applicationsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 30, 2019·0 cites·24 claims
- 1753US4596818AAmidinesBEECHAM GROUP PLC·Filed 1984·Granted Jun 24, 1986·5 cites·7 claims
- 1848US2008275040A18-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns DisordersGLAXO GROUP LTD·Filed 2004·Application pending·0 cites
- 1947US7528151B2Heterocyclic urea derivatives for the treatment of painGLAXO GROUP LTD·Filed 2004·Granted May 5, 2009·0 cites·6 claims
- 2047US7045619B22-(pyrazol-3-yl)carbapenem derivativesSMITHKLINE BEECHAM PLC·Filed 2002·Granted May 16, 2006·0 cites·5 claims
- 2146US12146004B2Polymyxin compounds and uses thereofNEW PHARMA LICENCE HOLDINGS LTD·Filed 2015·Granted Nov 19, 2024·0 cites·26 claims
- 2245US2007232657A1Novel compoundsGLAXO GROUP LTD·Filed 2007·Application pending·0 cites
- 2344US2009012056A1Quinoline Compounds Capable of Binding the Cb2 and/or the 5-Ht6 ReceptorGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
- 2444US2017073373A1Polymyxin derivatives and their use in combination therapy together with different antibioticsNEW PHARMA LICENCE HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 2543US2005124626A1Novel compoundsFiled 2003·Application pending·0 cites
- 2643US2002147333A12-(pyrazol-3-yl)carbapenem derivativesSMITHKLINE BEECHAM PLC·Filed 2002·Application pending·0 cites
- 2742US2005176759A17-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment cns disordersFiled 2002·Application pending·0 cites
- 2841US2005222124A1Benzenesulfonamide derivatives as antipsychotic agentsBROMIDGE STEVEN M·Filed 2003·Application pending·0 cites
- 2941US2005090485A17-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disordersFiled 2003·Application pending·0 cites
- 3041US2004192671A1Benzo[d]azepine derivatives as 5-ht6 receptor anatagonistsFiled 2002·Application pending·0 cites
- 3140US2004034036A1N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamideFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen Frederick Moss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →